Bayer AG Chief Executive Officer Marijn Dekkers

Bayer AG Chief Executive Officer Marijn Dekkers

Chris Ratcliffe/Bloomberg

Bayer AG Chief Executive Officer Marijn Dekkers faces competition for the blood thinner Xarelto, Bayer’s biggest new drug, from a Pfizer Inc. product.